According to IMARC Group’s latest report, titled “High Content Screening Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global high content screening market exhibited strong growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of 8.2% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
High-content screening (HCS), or cellomics, refers to the analytical method that combines automated imaging and quantitative data analysis to evaluate various biochemical and physical characteristics of sample cells. It aids in drug discovery, complex multivariate drug profiling and toxicity studies by utilizing robots, detectors and software to monitor the entire process.
Request Free Sample Report: https://www.imarcgroup.com/high-content-screening-market/requestsample
The key factor driving the global HCS market is the rising cases of chronic diseases like HIV-AIDS, epilepsy, and Parkinson’s diseases, which require intensive treatment. HCS solutions are inexpensive, resource- and time-efficient, and needed for determining the toxicity of chemicals and complex substances in the pharmaceutical industry. Moreover, several leading manufacturers are developing innovative HCS equipment integrated with software platforms and artificial intelligence (AI) systems to enhance the visualization capabilities of the devices. These technological advancements are expected to create a positive outlook for the market in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/high-content-screening-market
List of Key Companies Covered in this Market Report:
- Dickinson and Company
- Bio-Rad Laboratories Inc.
- Biotek Instruments Inc.
- Danaher Corporation
- GE Healthcare
- Merck Millipore
- Perkinelmer Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific
- Yokogawa Electric Corporation
The report has segmented the market on the basis of product, formulation, application and geography.
Breakup by Product:
- Cell Imaging and Analysis Systems
Breakup by Application:
- Target Identification and Validation
- Primary Screening and Secondary Screening
- Toxicity Studies
- Compound Profiling
- Other Applications
Breakup by End-User:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations (CROs)
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800